Navigation Links
JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control
Date:9/8/2008

NEW YORK, September 8, 2008 Patients with type 1 diabetes who used continuous glucose monitoring (CGM) devices to help manage their disease experienced significant improvements in blood sugar control, according to initial results of a major multicenter clinical trial funded by the Juvenile Diabetes Research Foundation. Results from the study were presented today during the European Association for the Study of Diabetes (EASD) annual meeting in Rome, and portions of the data will be published in the October 2 issue of the New England Journal of Medicine, available on line today at nejm.org.

The CGM study is a randomized, controlled trial involving 322 patients spanning the age range of 8 to 72 years at 10 sites, which included academic, community, and managed care based practices at the Atlanta Diabetes Associates, the Joslin Diabetes Center, Kaiser Permanente Southern California, Nemours Children's Clinic - Jacksonville, FL, the Lucile Packard Children's Hospital at Stanford University, the Barbara Davis Center for Childhood Diabetes at the University of Colorado Denver, the University of Iowa, the University of Washington, and Yale University, and coordinated by the Jaeb Center for Health Research in Tampa, Florida. Patients were assigned to either CGM or a control group using standard blood sugar monitoring and were followed for 26 weeks to assess effects on blood sugar control, principally assessed by measurement of the HbA1c level. At enrollment into the study, patients had HbA1c levels of 7-to-10% (the goal for adults with type 1 diabetes generally is a level below 7% and for children and adolescents below 7.5-8%). Three age groups were analyzed separately: 8 to 14 years of age, 15 to 24 years of age, and 25 years of age or older.

Improvements in blood sugar control were greatest for CGM patients 25 years of age or older, whose HbA1c levels decreased (improved) during the study by an average of 0.53% compared with control patien
'/>"/>

Contact: Jillian Lubarsky
jlubarsky@jdrf.org
212-479-7626
Juvenile Diabetes Research Foundation International
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. New study spotlights National Institutes of Health grant outcomes for clinical research
2. NCI grant launches clinical trials for colon cancer screening
3. Florida researchers receive JDRF Excellence in Clinical Research Award
4. A nutritional supplement could improve the clinical situation of ICU patients
5. NIH expands national consortium dedicated to transforming clinical and translational research
6. Peter J. McGuire, MB BCh, is awarded the 2008-2009 Genzyme/ACMGF Clinical Genetics Fellowship
7. Clinical trial that may help patients breathe easier begins at Central DuPage Hospital
8. The Lancet publishes first clinical trial data of a fully bioabsorbable drug eluting stent
9. NHLBI issues first US von Willebrand Disease clinical practice guidelines
10. Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines
11. Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Bochum,s medics have succeeded in treating cerebral palsy with ... brain damage, a 2.5 year old boy had been ... of survival. Just two months after treatment with the ... over the following months, the child learned to speak ... those from a Korean study, dispel the long-held doubts ...
(Date:5/23/2013)... Neuron , the team reveal the interplay of ... funded by the Wellcome Trust and BBSRC. , ... we improve our perceptual abilities. While these changes can ... also affect the fidelity of that response. ... explains: "When you communicate with others, you can make ...
(Date:5/22/2013)... conclude that the 20 percent reduction in lung ... chest X-ray (CXR) screening previously reported in the ... centers in the United States. , Philadelphia, PAPhysicians ... about the benefits and risks of LDCT lung ... New England Journal of Medicine of the ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3
... only to be central to the process that causes ... muting the high from methamphetamine and other addictive drugs. ... cation transporter 3 or oct3, fills a longstanding gap ... symptoms like tremor, stiffness, slowness of movement and postural ...
... Wash. -- Researchers have detected common plant toxins that ... fires. The results from the new study also suggest ... - a reason to keep human exposures to a ... -- known as alkaloids -- helps researchers understand how ...
... scientists from Cornell University have developed a new tool ... the origins of specific gene mutations. This research, published ... ( http://www.genetics.org ), helps shed light on times ... helps scientists close in on gene mutations that make ...
Cached Biology News:Brain protein central to both Parkinson's, drug addiction identified 2Brain protein central to both Parkinson's, drug addiction identified 3Brain protein central to both Parkinson's, drug addiction identified 4Potentially harmful chemicals found in forest fire smoke 2Tiny differences in our genes help shed light on the big picture of human history 2
(Date:5/23/2013)... Korea , May 23, 2013 ... SillaJen, Inc., a private biotherapeutics and contract research ... biological products for cancer, announced today a publication ... patients treated with the oncolytic and immunotherapeutic vaccinia ... This research was published in the May 15 ...
(Date:5/23/2013)... Bed bugs compromised Penn State. A ... it. Meanwhile, My Cleaning Products offered complimentary samples of its ... pests without using harmful chemical elements. , Based on ... affected building was actually a dormitory , My Cleaning ... on May 13 and bed bug presence was confirmed on ...
(Date:5/22/2013)... PA (PRWEB) May 22, 2013 Oven ... with the integrated potentiometers or via a PC ... design measuring two and one half inches square can ... a zero voltage switched, low noise solid state relay. ... power isolation for the communication port and sensor input. ...
(Date:5/22/2013)... The Conference Forum announced the launch ... Trials conference taking place on September 19-20 at the ... Disruptive thinkers from Novartis, Pfizer, Eli Lilly, Shire, Medimmune, ... reduce expensive infrastructure, engage patients and generate credible clinical ... or novel, or it must change the very nature ...
Breaking Biology Technology:Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2New AC Temperature Controller Announced by Oven Industries 2Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2
... , ... Kuantan, Malaysia facility awarded ISO13485 medical manufacturing certification. , ... Weybridge, United Kingdom (PRWEB) January ... today that its manufacturing facility in Kuantan, Malaysia has received ISO 13485:2003 medical ...
... , WASHINGTON , Jan. 22 The Advisory Board ... conference call hosted by Robert W. Musslewhite , Chief Executive Officer ... Company,s financial results for the quarter ended December 31, 2009 . ... at 6:00 p.m., Eastern Time .  The Company plans to release ...
... , , Twenty leading US ... the benefits of NIH funding through the 2009 Recovery and ... In advance of the one-year anniversary of the ... twenty of the nation,s leading research institutions, patient advocates and ...
Cached Biology Technology:All TT Electronics Integrated Manufacturing Services Facilities Accredited with Medical Manufacturing Standard 2The Advisory Board Company Schedules Third Quarter Conference Call for February 4, 2010 2A Recovery Act Success Story: NIH Funding of Biomedical Innovation Is Creating Jobs, Fueling Industry Growth, and Helping Reduce Long-term Health Care Costs 2A Recovery Act Success Story: NIH Funding of Biomedical Innovation Is Creating Jobs, Fueling Industry Growth, and Helping Reduce Long-term Health Care Costs 3